United Therapeutics (NASDAQ:UTHR) Stock Rating Lowered by StockNews.com

United Therapeutics (NASDAQ:UTHR – Get Free Report) was downgraded by investment analysts at StockNews.com from a “strong-buy” rating to a “buy” rating in a research report issued on Thursday. Several other equities research analysts have also issued reports on UTHR. Oppenheimer boosted their price target on shares of United Therapeutics from $575.00 to $600.00 and […]

Leave a Reply

Your email address will not be published.

Previous post Lear (NYSE:LEA) Stock Rating Upgraded by StockNews.com
Next post Critical Analysis: Innovex International (INVX) & Its Rivals